These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 8930150

  • 1. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ, Hutson PH, Kulagowski JJ, Leeson PD, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD.
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [Abstract] [Full Text] [Related]

  • 2. The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate receptor antagonist, L-701,324, in rodents.
    Bristow LJ, Flatman KL, Hutson PH, Kulagowski JJ, Leeson PD, Young L, Tricklebank MD.
    J Pharmacol Exp Ther; 1996 May; 277(2):578-85. PubMed ID: 8627534
    [Abstract] [Full Text] [Related]

  • 3. The anticonvulsant and behavioural profile of L-687,414, a partial agonist acting at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex.
    Tricklebank MD, Bristow LJ, Hutson PH, Leeson PD, Rowley M, Saywell K, Singh L, Tattersall FD, Thorn L, Williams BJ.
    Br J Pharmacol; 1994 Nov; 113(3):729-36. PubMed ID: 7858861
    [Abstract] [Full Text] [Related]

  • 4. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L.
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [Abstract] [Full Text] [Related]

  • 5. Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization.
    Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L, Przegalinski E, Kostowski W, Krzascik P, Chizh B, Headley PM.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1264-75. PubMed ID: 9400002
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.
    Gill R, Alanine A, Bourson A, Buttelmann B, Fischer G, Heitz MP, Kew JN, Levet-Trafit B, Lorez HP, Malherbe P, Miss MT, Mutel V, Pinard E, Roever S, Schmitt M, Trube G, Wybrecht R, Wyler R, Kemp JA.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):940-8. PubMed ID: 12183650
    [Abstract] [Full Text] [Related]

  • 7. Effects of the competitive N-methyl-D-aspartate antagonist CGP 37849 and its ethylester CGP 39551 on N-methyl-D-aspartate-evoked whole-cell currents in cultured spinal neurones and on vestibular stimulation-induced seizures in EL mice.
    D'Hooge R, Raes A, Hiramatsu M, Mori A, Van Bogaert PP, De Deyn PP.
    Arzneimittelforschung; 1998 Dec; 48(12):1121-5. PubMed ID: 9893924
    [Abstract] [Full Text] [Related]

  • 8. Anticonvulsant and behavioral effects of neuroactive steroids alone and in conjunction with diazepam.
    Gasior M, Carter RB, Goldberg SR, Witkin JM.
    J Pharmacol Exp Ther; 1997 Aug; 282(2):543-53. PubMed ID: 9262314
    [Abstract] [Full Text] [Related]

  • 9. 4-substituted-3-phenylquinolin-2(1H)-ones: acidic and nonacidic glycine site N-methyl-D-aspartate antagonists with in vivo activity.
    Carling RW, Leeson PD, Moore KW, Moyes CR, Duncton M, Hudson ML, Baker R, Foster AC, Grimwood S, Kemp JA, Marshall GR, Tricklebank MD, Saywell KL.
    J Med Chem; 1997 Feb 28; 40(5):754-65. PubMed ID: 9057862
    [Abstract] [Full Text] [Related]

  • 10. Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats.
    Yamashita H, Ohno K, Amada Y, Hattori H, Ozawa-Funatsu Y, Toya T, Inami H, Shishikura J, Sakamoto S, Okada M, Yamaguchi T.
    J Pharmacol Exp Ther; 2004 Jan 28; 308(1):127-33. PubMed ID: 14569061
    [Abstract] [Full Text] [Related]

  • 11. The role of probenecid-sensitive organic acid transport in the pharmacokinetics of N-methyl-D-aspartate receptor antagonists acting at the glycine(B)-site: microdialysis and maximum electroshock seizures studies.
    Hesselink MB, Smolders H, Eilbacher B, De Boer AG, Breimer DD, Danysz W.
    J Pharmacol Exp Ther; 1999 Aug 28; 290(2):543-50. PubMed ID: 10411561
    [Abstract] [Full Text] [Related]

  • 12. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
    Xiao ZY, Sun CK, Xiao XW, Lin YZ, Li S, Ma H, Song GR, Cheng R.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 19; 86(35):2479-84. PubMed ID: 17156678
    [Abstract] [Full Text] [Related]

  • 13. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
    Campbell BM, Kreipke CW, Walker PD.
    Neuroscience; 2006 Sep 19; 137(2):505-17. PubMed ID: 16289829
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM, Gasior M, Heifets B, Tortella FC.
    J Pharmacol Exp Ther; 1999 May 19; 289(2):703-11. PubMed ID: 10215643
    [Abstract] [Full Text] [Related]

  • 15. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T, Marshall GR, Hill RG, Kemp JA.
    Br J Pharmacol; 1998 Aug 19; 124(8):1767-73. PubMed ID: 9756395
    [Abstract] [Full Text] [Related]

  • 16. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN, Stephens DN.
    J Pharmacol Exp Ther; 1999 Jul 19; 290(1):9-15. PubMed ID: 10381753
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
    White HS, McCabe RT, Armstrong H, Donevan SD, Cruz LJ, Abogadie FC, Torres J, Rivier JE, Paarmann I, Hollmann M, Olivera BM.
    J Pharmacol Exp Ther; 2000 Jan 19; 292(1):425-32. PubMed ID: 10604979
    [Abstract] [Full Text] [Related]

  • 18. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A, Maj J.
    Pol J Pharmacol; 1993 Jan 19; 45(5-6):467-80. PubMed ID: 7912135
    [Abstract] [Full Text] [Related]

  • 19. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM, Steele TD, Sharpe LG.
    J Pharmacol Exp Ther; 1997 Jan 19; 280(1):46-52. PubMed ID: 8996180
    [Abstract] [Full Text] [Related]

  • 20. Preclinical evaluation of CHF3381 as a novel antiepileptic agent.
    Villetti G, Bregola G, Bassani F, Bergamaschi M, Rondelli I, Pietra C, Simonato M.
    Neuropharmacology; 2001 Jun 19; 40(7):866-78. PubMed ID: 11378157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.